NCT04163419 2024-03-13
Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis
Massachusetts General Hospital
Phase 2 Active not recruiting
Clinical Trials
3 trialsNCT02609828 2023-02-16
Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy
Pfizer
Phase 3 Completed
NCT00545129 2021-06-18
A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone
Pfizer
Phase 2 Completed